We have investigated the effects of adenosine i.v. on neuromuscular block induced by rocuronium, vecuronium and pipecuronium in an in vivo guinea-pig sciatic nerve-tibialis anterior preparation. The ED 50 of each neuromuscular blocker was determined from cumulative log dose-response regression lines (nϭ14). In separate experiments, adenosine 0.1 mg kg -1 min -1 or the same volume of 0.9% NaCl was given i.v. via a constant infusion and the ED 50 of each neuromuscular blocking agent was then administered (nϭ24). Adenosine 0.1 mg kg -1 min -1 increased significantly maximal block induced by the ED 50 of these neuromuscular blockers (55-72%, 49-73 % and 60-96 %, respectively, for rocuronium, vecuronium and pipecuronium; PϽ0.05). Time to maximal block after rocuronium was significantly prolonged by adenosine (1.4-2.1 min; PϽ0.05) and time to maximal block after vecuronium and pipecuronium was unchanged by adenosine. Time to maximal recovery of twitch tension after administration of the ED 50 of all neuromuscular blocking agents was prolonged significantly by adenosine (4.5-10.7 min, 8.2-15.8 min and 47.0-128.7 min, respectively, for rocuronium, vecuronium and pipecuronium; PϽ0.05). We conclude that continuous infusion of adenosine 0.1 mg kg -1 min -1 potentiated the effects of neuromuscular blocking agents in this in vivo guinea-pig preparation.
Adenosine and its analogues modulate synaptic transmission Methods and results
in a variety of tissues via the purinergic receptor (receptors After obtaining approval from the Institutional Animal Care for adenosine and adenine nucleotides). 1 2 At the neuromus-and Use Committee, 38 male guinea-pigs, weighing 300-cular junction, adenosine inhibits acetylcholine (ACh) 500 g, were anaesthetized with pentobarbital and urethane release via the presynaptic inhibitory A 1 purinoceptor. 1 3 i.p. The animals underwent tracheotomy and the lungs were Segerdahl and colleagues 4 showed that continuous adminis-ventilated with oxygen. Both jugular veins and one carotid tration of adenosine i.v. had antinociceptive effects in artery were cannulated for injection of drugs and monitoring patients during surgery. However, there have been no studies of arterial pressure and heart rate, respectively. Both sciatic regarding the effects of systemically administered adenosine nerves were isolated in the gluteal region, placed on bipolar on the action of neuromuscular blocking agents.
platinum electrodes and crushed with a heavy ligature To better understand the effects of systemically adminis-proximal to the electrode. The distal tendon of both tibialis tered adenosine on neuromuscular blocking agents, we have anterior muscles was dissected, separated from its insertion investigated the effect of adenosine on neuromuscular block and attached to FT03 transducers. Both sciatic nerves were stimulated with supramaximal square wave impulses of induced by different neuromuscular blocking agents, using 0.2 ms duration at 0.1 Hz and the force of contraction of an in vivo guinea-pig preparation. Previous work has shown both tibialis anterior muscles was recorded continuously. that the potencies and time courses of neuromuscular effect of neuromuscular blocking agents in guinea-pigs and †Deceased humans are similar. 5 (nϭ4) groups, respectively. The subsequent incremental Adenosine increased maximal block and prolonged the dose was 20 µg kg -1 , 2 µg kg -1 and 1 µg kg -1 in duration of block induced by all of the neuromuscular the rocuronium, vecuronium and pipecuronium groups, blocking agents. In vitro studies using mouse hemidirespectively. Each incremental dose was administered after aphragm 1 and frog sartorius muscle 3 revealed that adenosine three consecutive unchanged twitch responses were obtained potentiated the effects of neuromuscular blocking agents after the previous dose of drug; additional doses were not by inhibiting ACh release via a presynaptic inhibitory A 1 given when at least 95% depression of twitch height purinoceptor. Therefore, it seems likely that potentiation of occurred. Cumulative doses of each drug and neuromuscular neuromuscular blocking agents in our study was caused by responses were transformed to log-dose and probit-response A 1 receptor mediated inhibition of ACh release. values. ED 50 values were derived from least square linear Time to maximal block after rocuronium was prolonged regression analysis.
and that after vecuronium and pipecuronium was unchanged The interaction of adenosine and the neuromuscular by adenosine. The explanation of this finding is that blocking agents was studied in the other 24 guinea-pigs. the pharmacokinetic effects of adenosine (haemodynamic Adenosine 0.1 mg kg -1 min -1 or the same volume of 0.9% depressant effect, that is increase in the time of delivery of NaCl (control) was administered via a constant i.v. infusion neuromuscular blocking agent) affected the onset time of throughout the experiment and the ED 50 of rocuronium, rocuronium as it has the fastest baseline onset time. In a vecuronium or pipecuronium was given as a single i.v. dose study of magnesium sulphate, potentiation of the neuromus-(nϭ4 per group). After administration of each neuromuscu-cular blocking effects of blockers with shorter baseline lar blocking agent, maximal block of twitch tension, time onset times was less affected by magnesium sulphate. 6 to maximal block, maximal recovery of twitch tension and Although it was not statistically significant, adenosine time to maximal recovery were recorded.
shortened the time to maximal block after pipecuronium. Data were analysed using the unpaired Student's t test As pipecuronium has the longest baseline onset time, the and significance was assumed when PϽ0.05. Data are pharmacodynamic effects of adenosine influenced the onset presented as mean (SEM).
time of this blocker. The ED 50 of each neuromuscular blocking agent was 64
While adenosine increased neuromuscular block induced (8.7) µg kg -1 for rocuronium, 7 (1.9) µg kg -1 for vecuronium by neuromuscular blocking agents, it alone had no effect and 4 (0.7) µg kg -1 for pipecuronium.
on twitch tension. This could be explained by a high Table 1 summarizes the effects of adenosine on the margin of safety of neuromuscular transmission. Adenosine neuromuscular blocking agents. Continuous infusion of inhibited twitch tension only when the margin of safety adenosine 0.1 mg kg -1 min -1 alone had no effect on was reduced by rocuronium, vecuronium or pipecuronium. the height of the twitches, but significantly increased the In a mouse hemidiaphragm study, it has also been reported maximal block of twitch tension induced by all blocking that adenosine or its stable analogues inhibited nerve agents (PϽ0.05). Time to maximal block after vecuronium stimulation-evoked twitches only when the margin of safety and pipecuronium was unchanged by adenosine, but after was reduced by neuromuscular blocking agents or high rocuronium, it was significantly prolonged by adenosine [Mg 2ϩ ]. 1 (PϽ0.05). Time to maximal recovery of twitch tension In summary, adenosine potentiated the neuromuscular after all neuromuscular blocking agents was significantly blocking effects induced by rocuronium, vecuronium and pipecuronium and prolonged the time to maximal block prolonged by adenosine (PϽ0.05). 
